Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Cytomx Thera (CTMX)

Cytomx Thera (CTMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 149,604
  • Shares Outstanding, K 77,919
  • Annual Sales, $ 101,210 K
  • Annual Income, $ -570 K
  • 60-Month Beta 1.09
  • Price/Sales 1.46
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade CTMX with:

Options Overview Details

View History
  • Implied Volatility 120.99% ( -124.69%)
  • Historical Volatility 397.66%
  • IV Percentile 24%
  • IV Rank 8.45%
  • IV High 1,127.83% on 09/19/23
  • IV Low 28.02% on 06/21/23
  • Put/Call Vol Ratio 0.06
  • Today's Volume 37
  • Volume Avg (30-Day) 5,818
  • Put/Call OI Ratio 0.06
  • Today's Open Interest 22,130
  • Open Int (30-Day) 38,493

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.06
  • Number of Estimates 4
  • High Estimate 0.16
  • Low Estimate -0.25
  • Prior Year -0.02
  • Growth Rate Est. (year over year) -200.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.5800 +21.84%
on 04/29/24
5.8500 -67.09%
on 05/01/24
+0.2550 (+15.27%)
since 04/19/24
3-Month
1.4300 +34.62%
on 02/23/24
5.8500 -67.09%
on 05/01/24
+0.4750 (+32.76%)
since 02/21/24
52-Week
1.0400 +85.10%
on 10/30/23
5.8500 -67.09%
on 05/01/24
+0.0450 (+2.39%)
since 05/19/23

Most Recent Stories

More News
Biotech Companies Making Strides in Pancreatic Cancer Treatment and Early Detection

/CNW/ -- USA News Group – Hope is rising in the fight against one of the deadliest cancers in the world, as a new study recently claimed that a blood test can...

ONCY : 1.1050 (-1.34%)
CADL : 12.84 (+7.18%)
ABVC : 1.0800 (unch)
CTMX : 1.9200 (+1.04%)
AMGN : 313.80 (-0.24%)
ONC.TO : 1.51 (unch)
Biotech Innovations Drive Hope in Global Fight Against Pancreatic Cancer

USA News Group – Hope is rising in the fight against one of the deadliest cancers in the world, as a new study recently claimed that a blood test can accurately detect early-stage pancreatic cancer with...

ONCY : 1.1050 (-1.34%)
ONC.TO : 1.51 (unch)
CADL : 12.84 (+7.18%)
ABVC : 1.0800 (unch)
CTMX : 1.9200 (+1.04%)
AMGN : 313.80 (-0.24%)
CytomX Therapeutics: Q1 Earnings Snapshot

CytomX Therapeutics: Q1 Earnings Snapshot

CTMX : 1.9200 (+1.04%)
Stocks Set to Open Higher as Investors Await More Corporate Earnings and Fed Speak

June S&P 500 E-Mini futures (ESM24) are up +0.24%, and June Nasdaq 100 E-Mini futures (NQM24) are up +0.18% this morning as market participants looked ahead to a fresh batch of corporate earnings reports...

ESM24 : 5,334.00 (+0.04%)
NQM24 : 18,763.75 (unch)
AMGN : 313.80 (-0.24%)
AAPL : 192.04 (+0.52%)
ANET : 317.52 (-0.59%)
EXPE : 112.00 (-2.03%)
DIS : 102.99 (+0.09%)
TSN : 61.01 (+0.64%)
VRTX : 439.50 (-1.43%)
PLTR : 21.17 (-2.08%)
DDOG : 122.65 (+1.12%)
EA : 128.30 (-0.13%)
CytomX Therapeutics: Q3 Earnings Snapshot

CytomX Therapeutics: Q3 Earnings Snapshot

CTMX : 1.9200 (+1.04%)
CytomX Therapeutics: Q2 Earnings Snapshot

CytomX Therapeutics: Q2 Earnings Snapshot

CTMX : 1.9200 (+1.04%)
CytomX Therapeutics (CTMX) Reports Q1 Loss, Tops Revenue Estimates

CytomX Therapeutics (CTMX) delivered earnings and revenue surprises of 68.75% and 5.61%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

CTMX : 1.9200 (+1.04%)
AGLE : 12.01 (+8.79%)
CytomX Therapeutics: Q1 Earnings Snapshot

CytomX Therapeutics: Q1 Earnings Snapshot

CTMX : 1.9200 (+1.04%)
Codexis (CDXS) Reports Q1 Loss, Lags Revenue Estimates

Codexis (CDXS) delivered earnings and revenue surprises of -17.24% and 11.34%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

CDXS : 3.50 (+2.94%)
CTMX : 1.9200 (+1.04%)
Certara, Inc. (CERT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Certara, Inc. (CERT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CERT : 16.48 (+0.73%)
CTMX : 1.9200 (+1.04%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Buy with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

CytomX Therapeutics, Inc. is an oncology focused biopharmaceutical company. The Company is engaged in developing Probody(TM) therapeutics for the treatment of cancer. Its pipeline focuses areas consist of Precision cancer immunotherapy and Probody drug conjugates. CytomX Therapeutics, Inc. is headquartered...

See More

Key Turning Points

3rd Resistance Point 2.0633
2nd Resistance Point 2.0067
1st Resistance Point 1.9633
Last Price 1.9200
1st Support Level 1.8633
2nd Support Level 1.8067
3rd Support Level 1.7633

See More

52-Week High 5.8500
Fibonacci 61.8% 4.0126
Fibonacci 50% 3.4450
Fibonacci 38.2% 2.8774
Last Price 1.9200
52-Week Low 1.0400

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar